APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Valsartan Drug Market Outlook and Growth Opportunities 2026

20 December 2025208 pages

Choose your research edition.

Industry ResearchValsartan Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Valsartan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Drug Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Valsartan Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Valsartan Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Valsartan Drug market include Zhejiang Huahai Pharmaceutical, Teva, Sun Pharmaceutical, Novartis, Mylan, Huaren Pharmaceutical, Unichem Laboratories, Torrent Pharmaceuticals and Square Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan Drug Segment by Company

Zhejiang Huahai Pharmaceutical

Teva

Sun Pharmaceutical

Novartis

Mylan

Huaren Pharmaceutical

Unichem Laboratories

Torrent Pharmaceuticals

Square Pharmaceuticals

Macleods Pharmaceuticals

Lupin

Jubilant Pharma

HETERO

Aurobindo Pharma

Amneal Pharmaceuticals

Alembic Pharmaceuticals

Valsartan Drug Segment by Type

40 mg Tablets

80 mg Tablets

160 mg Tablets

320 mg Tablets

Valsartan Drug Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Valsartan Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valsartan Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valsartan Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Valsartan Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valsartan Drug industry.

Chapter 3: Detailed analysis of Valsartan Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valsartan Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valsartan Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valsartan Drug Industry Trends Table 2. Valsartan Drug Industry Drivers Table 3. Valsartan Drug Industry Opportunities and Challenges Table 4. Valsartan Drug Industry Restraints Table 5. Global Valsartan Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valsartan Drug Revenue Share by Company (2021-2026) Table 7. Global Valsartan Drug Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Valsartan Drug Sales Volume Share by Company (2021-2026) Table 9. Global Valsartan Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Valsartan Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valsartan Drug Key Company Manufacturing Base & Headquarters Table 12. Global Valsartan Drug Company, Product Type & Application Table 13. Global Valsartan Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40 mg Tablets Table 18. Significant Companies of 80 mg Tablets Table 19. Significant Companies of 160 mg Tablets Table 20. Significant Companies of 320 mg Tablets Table 21. Global Valsartan Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Valsartan Drug Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Valsartan Drug Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Valsartan Drug Sales Volume Share by Type (2021-2026) Table 25. Global Valsartan Drug Sales Volume Share by Type (2027-2032) Table 26. Global Valsartan Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Valsartan Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Valsartan Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Valsartan Drug Sales Value Share by Type (2021-2026) Table 30. Global Valsartan Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Heart Failure Table 32. Significant Companies of Heart Attack Table 33. Significant Companies of Hypertension Table 34. Global Valsartan Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Valsartan Drug Sales Volume by Application (2021-2026) & (W Units) Table 36. Global Valsartan Drug Sales Volume by Application (2027-2032) & (W Units) Table 37. Global Valsartan Drug Sales Volume Share by Application (2021-2026) Table 38. Global Valsartan Drug Sales Volume Share by Application (2027-2032) Table 39. Global Valsartan Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Valsartan Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Valsartan Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Valsartan Drug Sales Value Share by Application (2021-2026) Table 43. Global Valsartan Drug Sales Value Share by Application (2027-2032) Table 44. Global Valsartan Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Valsartan Drug Sales by Region (2021-2026) & (W Units) Table 46. Global Valsartan Drug Sales Market Share by Region (2021-2026) Table 47. Global Valsartan Drug Sales by Region (2027-2032) & (W Units) Table 48. Global Valsartan Drug Sales Market Share by Region (2027-2032) Table 49. Global Valsartan Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Valsartan Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Valsartan Drug Sales Value Share by Region (2021-2026) Table 52. Global Valsartan Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Valsartan Drug Sales Value Share by Region (2027-2032) Table 54. Global Valsartan Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Valsartan Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Valsartan Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Global Valsartan Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 59. Global Valsartan Drug Sales Market Share by Country (2021-2026) Table 60. Global Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 61. Global Valsartan Drug Sales Market Share by Country (2027-2032) Table 62. Global Valsartan Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Valsartan Drug Sales Value Market Share by Country (2021-2026) Table 64. Global Valsartan Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Valsartan Drug Sales Value Market Share by Country (2027-2032) Table 66. Zhejiang Huahai Pharmaceutical Company Information Table 67. Zhejiang Huahai Pharmaceutical Business Overview Table 68. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio Table 70. Zhejiang Huahai Pharmaceutical Recent Development Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Valsartan Drug Product Portfolio Table 75. Teva Recent Development Table 76. Sun Pharmaceutical Company Information Table 77. Sun Pharmaceutical Business Overview Table 78. Sun Pharmaceutical Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sun Pharmaceutical Valsartan Drug Product Portfolio Table 80. Sun Pharmaceutical Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Novartis Valsartan Drug Product Portfolio Table 85. Novartis Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Mylan Valsartan Drug Product Portfolio Table 90. Mylan Recent Development Table 91. Huaren Pharmaceutical Company Information Table 92. Huaren Pharmaceutical Business Overview Table 93. Huaren Pharmaceutical Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Huaren Pharmaceutical Valsartan Drug Product Portfolio Table 95. Huaren Pharmaceutical Recent Development Table 96. Unichem Laboratories Company Information Table 97. Unichem Laboratories Business Overview Table 98. Unichem Laboratories Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Unichem Laboratories Valsartan Drug Product Portfolio Table 100. Unichem Laboratories Recent Development Table 101. Torrent Pharmaceuticals Company Information Table 102. Torrent Pharmaceuticals Business Overview Table 103. Torrent Pharmaceuticals Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Torrent Pharmaceuticals Valsartan Drug Product Portfolio Table 105. Torrent Pharmaceuticals Recent Development Table 106. Square Pharmaceuticals Company Information Table 107. Square Pharmaceuticals Business Overview Table 108. Square Pharmaceuticals Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Square Pharmaceuticals Valsartan Drug Product Portfolio Table 110. Square Pharmaceuticals Recent Development Table 111. Macleods Pharmaceuticals Company Information Table 112. Macleods Pharmaceuticals Business Overview Table 113. Macleods Pharmaceuticals Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Macleods Pharmaceuticals Valsartan Drug Product Portfolio Table 115. Macleods Pharmaceuticals Recent Development Table 116. Lupin Company Information Table 117. Lupin Business Overview Table 118. Lupin Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Lupin Valsartan Drug Product Portfolio Table 120. Lupin Recent Development Table 121. Jubilant Pharma Company Information Table 122. Jubilant Pharma Business Overview Table 123. Jubilant Pharma Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Jubilant Pharma Valsartan Drug Product Portfolio Table 125. Jubilant Pharma Recent Development Table 126. HETERO Company Information Table 127. HETERO Business Overview Table 128. HETERO Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. HETERO Valsartan Drug Product Portfolio Table 130. HETERO Recent Development Table 131. Aurobindo Pharma Company Information Table 132. Aurobindo Pharma Business Overview Table 133. Aurobindo Pharma Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Aurobindo Pharma Valsartan Drug Product Portfolio Table 135. Aurobindo Pharma Recent Development Table 136. Amneal Pharmaceuticals Company Information Table 137. Amneal Pharmaceuticals Business Overview Table 138. Amneal Pharmaceuticals Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Amneal Pharmaceuticals Valsartan Drug Product Portfolio Table 140. Amneal Pharmaceuticals Recent Development Table 141. Alembic Pharmaceuticals Company Information Table 142. Alembic Pharmaceuticals Business Overview Table 143. Alembic Pharmaceuticals Valsartan Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Alembic Pharmaceuticals Valsartan Drug Product Portfolio Table 145. Alembic Pharmaceuticals Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Valsartan Drug Distributors List Table 149. Valsartan Drug Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Valsartan Drug Product Image Figure 2. Global Valsartan Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valsartan Drug Sales (2021-2032) & (W Units) Figure 5. Global Valsartan Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Valsartan Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40 mg Tablets Image Figure 10. 80 mg Tablets Image Figure 11. 160 mg Tablets Image Figure 12. 320 mg Tablets Image Figure 13. Global Valsartan Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Valsartan Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Valsartan Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Valsartan Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Valsartan Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Valsartan Drug Sales Value Share by Type (2021-2032) Figure 19. Heart Failure Image Figure 20. Heart Attack Image Figure 21. Hypertension Image Figure 22. Global Valsartan Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Valsartan Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Valsartan Drug Sales Volume Share by Application (2021-2032) Figure 25. Global Valsartan Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Valsartan Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Valsartan Drug Sales Value Share by Application (2021-2032) Figure 28. Global Valsartan Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 29. Global Valsartan Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Valsartan Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Valsartan Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Valsartan Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America Valsartan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Valsartan Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Valsartan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Valsartan Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Valsartan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Valsartan Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America Valsartan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Valsartan Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Valsartan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Valsartan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Valsartan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Valsartan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Valsartan Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Valsartan Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 40 mg Tablets
  • 80 mg Tablets
  • 160 mg Tablets
  • 320 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Huaren Pharmaceutical
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Square Pharmaceuticals
  • Macleods Pharmaceuticals
  • Lupin
  • Jubilant Pharma
  • HETERO
  • Aurobindo Pharma
  • Amneal Pharmaceuticals
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan Drug Sales Value (2021-2032)
  4. 1.2.2 Global Valsartan Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Valsartan Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valsartan Drug Market Dynamics
  1. 2.1 Valsartan Drug Industry Trends
  2. 2.2 Valsartan Drug Industry Drivers
  3. 2.3 Valsartan Drug Industry Opportunities and Challenges
  4. 2.4 Valsartan Drug Industry Restraints
3 Valsartan Drug Market by Company
  1. 3.1 Global Valsartan Drug Company Revenue Ranking in 2025
  2. 3.2 Global Valsartan Drug Revenue by Company (2021-2026)
  3. 3.3 Global Valsartan Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Valsartan Drug Average Price by Company (2021-2026)
  5. 3.5 Global Valsartan Drug Company Ranking (2024-2026)
  6. 3.6 Global Valsartan Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Valsartan Drug Company Product Type and Application
  8. 3.8 Global Valsartan Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valsartan Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valsartan Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valsartan Drug Market by Type
  1. 4.1 Valsartan Drug Type Introduction
  2. 4.1.1 40 mg Tablets
  3. 4.1.2 80 mg Tablets
  4. 4.1.3 160 mg Tablets
  5. 4.1.4 320 mg Tablets
  6. 4.2 Global Valsartan Drug Sales Volume by Type
  7. 4.2.1 Global Valsartan Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valsartan Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Valsartan Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Valsartan Drug Sales Value by Type
  11. 4.3.1 Global Valsartan Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valsartan Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Valsartan Drug Sales Value Share by Type (2021-2032)
5 Valsartan Drug Market by Application
  1. 5.1 Valsartan Drug Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Heart Attack
  4. 5.1.3 Hypertension
  5. 5.2 Global Valsartan Drug Sales Volume by Application
  6. 5.2.1 Global Valsartan Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Valsartan Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Valsartan Drug Sales Value by Application
  10. 5.3.1 Global Valsartan Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valsartan Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Valsartan Drug Sales Value Share by Application (2021-2032)
6 Valsartan Drug Regional Sales and Value Analysis
  1. 6.1 Global Valsartan Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Valsartan Drug Sales by Region (2027-2032)
  5. 6.3 Global Valsartan Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valsartan Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valsartan Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valsartan Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Valsartan Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valsartan Drug Sales Value (2021-2032)
  12. 6.6.2 North America Valsartan Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valsartan Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Valsartan Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valsartan Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valsartan Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valsartan Drug Sales Value (2021-2032)
  21. 6.9.2 South America Valsartan Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valsartan Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valsartan Drug Sales Value Share by Country, 2025 VS 2032
7 Valsartan Drug Country-level Sales and Value Analysis
  1. 7.1 Global Valsartan Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valsartan Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valsartan Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Valsartan Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Valsartan Drug Sales by Country (2027-2032)
  6. 7.4 Global Valsartan Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valsartan Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valsartan Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valsartan Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valsartan Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valsartan Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valsartan Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valsartan Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valsartan Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valsartan Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valsartan Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valsartan Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valsartan Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valsartan Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valsartan Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valsartan Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valsartan Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valsartan Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valsartan Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valsartan Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valsartan Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valsartan Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valsartan Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valsartan Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valsartan Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valsartan Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valsartan Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valsartan Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valsartan Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valsartan Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valsartan Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valsartan Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valsartan Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valsartan Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Valsartan Drug Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Valsartan Drug Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Valsartan Drug Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Valsartan Drug Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Huaren Pharmaceutical
  32. 8.6.1 Huaren Pharmaceutical Company Information
  33. 8.6.2 Huaren Pharmaceutical Business Overview
  34. 8.6.3 Huaren Pharmaceutical Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Huaren Pharmaceutical Valsartan Drug Product Portfolio
  36. 8.6.5 Huaren Pharmaceutical Recent Developments
  37. 8.7 Unichem Laboratories
  38. 8.7.1 Unichem Laboratories Company Information
  39. 8.7.2 Unichem Laboratories Business Overview
  40. 8.7.3 Unichem Laboratories Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Unichem Laboratories Valsartan Drug Product Portfolio
  42. 8.7.5 Unichem Laboratories Recent Developments
  43. 8.8 Torrent Pharmaceuticals
  44. 8.8.1 Torrent Pharmaceuticals Company Information
  45. 8.8.2 Torrent Pharmaceuticals Business Overview
  46. 8.8.3 Torrent Pharmaceuticals Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharmaceuticals Valsartan Drug Product Portfolio
  48. 8.8.5 Torrent Pharmaceuticals Recent Developments
  49. 8.9 Square Pharmaceuticals
  50. 8.9.1 Square Pharmaceuticals Company Information
  51. 8.9.2 Square Pharmaceuticals Business Overview
  52. 8.9.3 Square Pharmaceuticals Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Square Pharmaceuticals Valsartan Drug Product Portfolio
  54. 8.9.5 Square Pharmaceuticals Recent Developments
  55. 8.10 Macleods Pharmaceuticals
  56. 8.10.1 Macleods Pharmaceuticals Company Information
  57. 8.10.2 Macleods Pharmaceuticals Business Overview
  58. 8.10.3 Macleods Pharmaceuticals Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Macleods Pharmaceuticals Valsartan Drug Product Portfolio
  60. 8.10.5 Macleods Pharmaceuticals Recent Developments
  61. 8.11 Lupin
  62. 8.11.1 Lupin Company Information
  63. 8.11.2 Lupin Business Overview
  64. 8.11.3 Lupin Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lupin Valsartan Drug Product Portfolio
  66. 8.11.5 Lupin Recent Developments
  67. 8.12 Jubilant Pharma
  68. 8.12.1 Jubilant Pharma Company Information
  69. 8.12.2 Jubilant Pharma Business Overview
  70. 8.12.3 Jubilant Pharma Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Jubilant Pharma Valsartan Drug Product Portfolio
  72. 8.12.5 Jubilant Pharma Recent Developments
  73. 8.13 HETERO
  74. 8.13.1 HETERO Company Information
  75. 8.13.2 HETERO Business Overview
  76. 8.13.3 HETERO Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 HETERO Valsartan Drug Product Portfolio
  78. 8.13.5 HETERO Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma Valsartan Drug Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
  85. 8.15 Amneal Pharmaceuticals
  86. 8.15.1 Amneal Pharmaceuticals Company Information
  87. 8.15.2 Amneal Pharmaceuticals Business Overview
  88. 8.15.3 Amneal Pharmaceuticals Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Amneal Pharmaceuticals Valsartan Drug Product Portfolio
  90. 8.15.5 Amneal Pharmaceuticals Recent Developments
  91. 8.16 Alembic Pharmaceuticals
  92. 8.16.1 Alembic Pharmaceuticals Company Information
  93. 8.16.2 Alembic Pharmaceuticals Business Overview
  94. 8.16.3 Alembic Pharmaceuticals Valsartan Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Alembic Pharmaceuticals Valsartan Drug Product Portfolio
  96. 8.16.5 Alembic Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan Drug Value Chain Analysis
  2. 9.1.1 Valsartan Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan Drug Sales Mode & Process
  6. 9.2 Valsartan Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan Drug Distributors
  9. 9.2.3 Valsartan Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst